FILZEPH
Live / Registered — Registered (as of 22 Jul 2025)
What this means for you
Registered since 22 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98010526
- Registration number
- 7870383
- Mark type
- Stylized text
- Filed
- 24 May 2023
- Published for opposition
- 16 Apr 2024
- Registered
- 22 Jul 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 22 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 27 Jun 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 07 Nov 2024 — NOTICE OF ALLOWANCE CANCELLED
- 27 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Nov 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 11 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2024 — PUBLISHED FOR OPPOSITION
- 27 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Mar 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED